{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:44:51Z","timestamp":1785901491512,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"National Council on Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.msard.2025.106604","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:43:28Z","timestamp":1751427808000},"page":"106604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["LATAM-Panorama-NMOSD: Epidemiological, Clinical, and Paraclinical Features of Neuromyelitis Optica Spectrum Disorder in Latin America and the Caribbean, A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6157-9007","authenticated-orcid":false,"given":"Gabriela","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2311-1665","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Inzunza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","article-title":"Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0044","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1352458509353651","article-title":"Recurrent neuromyelitis optica in Brazilian patients: Clinical, immunological, and neuroimaging characteristics","volume":"16","author":"Adoni","year":"2010","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.msard.2025.106604_bib0031","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/0004-282x-anp-2020-0527","article-title":"Correlation between Amerindian ancestry and neuromyelitis optica spectrum disorders (NMSOD) among patients in Midwestern Brazil","volume":"80","author":"Alves","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"issue":"8","key":"10.1016\/j.msard.2025.106604_bib0055","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1007\/s00415-024-12452-8","article-title":"Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis","volume":"271","author":"Arnett","year":"2024","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12874-021-01381-z","article-title":"Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence","volume":"21","author":"Barker","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.msard.2025.106604_bib0029","article-title":"Clinical features and frequency of area postrema syndrome in neuromyelitis optica spectrum disorder: A single-center study in Mexico","volume":"9","author":"Bertado-Cort\u00e9s","year":"2023","journal-title":"Brain Disord [Internet]."},{"issue":"5","key":"10.1016\/j.msard.2025.106604_bib0039","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1352458508101935","article-title":"Neuromyelitis optica in Brazil: A study on clinical and prognostic factors","volume":"15","author":"Bichuetti","year":"2009","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-G\u00f3mez","year":"2009","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.msard.2025.106604_bib0041","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s10072-023-06611-4","article-title":"Neuromyelitis optica spectrum disorders with and without associated autoimmune diseases","volume":"44","author":"Carnero Contentti","year":"2023","journal-title":"Neurol Sci"},{"key":"10.1016\/j.msard.2025.106604_bib0021","article-title":"Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study","volume":"46","author":"Carnero","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2025.106604_bib0046","article-title":"Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina","volume":"58","author":"Carnero","year":"2022","journal-title":"Mult Scler Relat Disord [Internet]."},{"key":"10.1016\/j.msard.2025.106604_bib0030","article-title":"Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America","volume":"72","author":"Carnero","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"10.1016\/j.msard.2025.106604_bib0036","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1177\/13524585231187120","article-title":"Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting","volume":"29","author":"Carnero","year":"2023","journal-title":"Mult Scler J"},{"issue":"4","key":"10.1016\/j.msard.2025.106604_bib0037","article-title":"Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry","volume":"9","author":"Carnero","year":"2023","journal-title":"Mult Scler J - Exp Transl Clin"},{"key":"10.1016\/j.msard.2025.106604_bib0057","unstructured":"Caribbean EC for LA and the. The World Has 8 Billion People, 662 Million of Whom Live in Latin America and the Caribbean [Internet]. Economic Commission for Latin America and the Caribbean; [cited 2024 Nov 24]. Available from: https:\/\/www.cepal.org\/en\/news\/world-has-8-billion-people-662-million-whom-live-latin-america-and-caribbean."},{"key":"10.1016\/j.msard.2025.106604_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103919","article-title":"Clinical and paraclinical profile of neuromyelitis optic spectrum disorder in a peruvian cohort","volume":"64","author":"Castro-Suarez","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2025.106604_bib0013","doi-asserted-by":"crossref","unstructured":"Eden J, Levit L, Berg A, Morton S, editors. Finding What Works in Health Care: Standards for Systematic Reviews [Internet]. Washington, D.C.: National Academies Press; 2011 [cited 2024 Nov 24]. Available from: https:\/\/www.nap.edu\/catalog\/13059.","DOI":"10.17226\/13059"},{"key":"10.1016\/j.msard.2025.106604_bib0027","article-title":"Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort","volume":"44","author":"Edgar","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2025.106604_bib57","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106604_bib0028","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.msard.2018.11.031","article-title":"Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD)","volume":"27","author":"Fragoso","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0026","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12883-022-02621-5","article-title":"Clinical and prognostic aspects of patients with the Neuromyelitis Optica Spectrum Disorder (NMOSD) from a cohort in Northeast Brazil","volume":"22","author":"Fukuda","year":"2022","journal-title":"BMC Neurol"},{"issue":"12","key":"10.1016\/j.msard.2025.106604_bib0048","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2105\/AJPH.2005.068668","article-title":"Latino Populations: A Unique Opportunity for the Study of Race, Genetics, and Social Environment in Epidemiological Research","volume":"95","author":"Gonz\u00e1lez","year":"2005","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0007","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/neurolint14010023","article-title":"Neuromyelitis Optica Spectrum Disorder in Central America and the Caribbean: A Multinational Clinical Characterization Study","volume":"14","author":"Gracia","year":"2022","journal-title":"Neurol Int"},{"key":"10.1016\/j.msard.2025.106604_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.msard.2025.106604_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102652","article-title":"Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study","volume":"47","author":"Ibis","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0002","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1186\/1742-2094-10-8","article-title":"The history of neuromyelitis optica","volume":"10","author":"Jarius","year":"2013","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0054","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.msard.2025.106604_bib0049","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.230832","article-title":"The fallacy of global comparisons based on per capita measures","volume":"11","author":"Kratochv\u00edl","year":"2024","journal-title":"R Soc Open Sci"},{"issue":"9451","key":"10.1016\/j.msard.2025.106604_bib0003","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.msard.2025.106604_bib0043","article-title":"Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte","volume":"50","author":"MA","year":"2021","journal-title":"Southeast Brazil. Mult Scler Relat Disord"},{"issue":"9","key":"10.1016\/j.msard.2025.106604_bib0004","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.msard.2025.106604_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103733","article-title":"Neuromyelitis optica spectrum disorder in Western Mexico","volume":"61","author":"Mireles-Ram\u00edrez","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2025.106604_bib0047","article-title":"The prevalence, incidence, and clinical assessment of neuromyelitis optica spectrum disorder in patients with demyelinating diseases","author":"Mireles-Ram\u00edrez","year":"2022","journal-title":"Neurol Engl Ed"},{"key":"10.1016\/j.msard.2025.106604_bib0009","article-title":"Prevalence of neuromyelitis optica spectrum disorder in antioquia between 2016 and 2018","volume":"60","author":"Mu\u00f1oz","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2025.106604_bib0012","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.msard.2025.106604_bib0042","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jnnp.73.4.429","article-title":"Optic neuromyelitis syndrome in Brazilian patients","volume":"73","author":"Papais-Alvarenga","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.msard.2025.106604_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127757","article-title":"Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study","volume":"10","author":"Papais-Alvarenga","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.msard.2025.106604_bib0008","unstructured":"Papp V. Worldwide Incidence and Prevalence of Neuromyelitis Optica. n. d."},{"issue":"3","key":"10.1016\/j.msard.2025.106604_bib0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/neu.2016.49","article-title":"Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica","volume":"29","author":"Pereira","year":"2017","journal-title":"Acta Neuropsychiatr"},{"issue":"7","key":"10.1016\/j.msard.2025.106604_bib0024","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jocn.2011.10.009","article-title":"Brain MRI abnormalities in Brazilian patients with neuromyelitis optica","volume":"19","author":"Pires","year":"2012","journal-title":"J Clin Neurosci"},{"issue":"7","key":"10.1016\/j.msard.2025.106604_bib0001","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in Aquaporin-4\u2013Positive Neuromyelitis Optica Spectrum Disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.msard.2025.106604_bib0052","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/00064246.2015.1012997","article-title":"Legacy, and Lineage in the Dominican Republic: Shifting Paradigms","volume":"45","author":"Race","year":"2015","journal-title":"Black Sch"},{"key":"10.1016\/j.msard.2025.106604_bib0016","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.msard.2025.106604_bib0011","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of Devic\u2019s disease (neuromyelitis optica) in Mexico","volume":"255","author":"Rivera","year":"2008","journal-title":"J Neurol."},{"key":"10.1016\/j.msard.2025.106604_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103083","article-title":"Status of the neuromyelitis optica spectrum disorder in Latin America","volume":"53","author":"Rivera","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"10.1016\/j.msard.2025.106604_bib0038","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10072-019-04230-6","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)","volume":"41","author":"Rojas","year":"2020","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0032","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10072-022-06409-w","article-title":"Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina","volume":"44","author":"Rojas","year":"2023","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69224-3","article-title":"Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population","volume":"10","author":"Romero-Hidalgo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.msard.2025.106604_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103080","article-title":"Asian and African\/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence","volume":"53","author":"Soares-dos-Reis","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2025.106604_bib0014","unstructured":"Stata C. Stata 18. StataCorp LLC.; 2023. (Stata)."},{"key":"10.1016\/j.msard.2025.106604_bib0015","unstructured":"StataCorp. Stata 18 Meta-Analysis Reference Manual. College Station, TX: Stata Press; 2023."},{"key":"10.1016\/j.msard.2025.106604_bib0020","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.msard.2025.106604_bib0034","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuarg.2018.06.001","article-title":"Epidemiology of neuromyelitis optica in Costa Rica: A multicenter analysis","volume":"10","author":"V\u00e1squez","year":"2018","journal-title":"Neurol Argent"},{"key":"10.1016\/j.msard.2025.106604_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104114","article-title":"Risk factors associated with permanent disability in neuromyelitis optica spectrum disorders","volume":"68","author":"Valdivia-Tangarife","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2025.106604_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105018","article-title":"Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based study","volume":"79","author":"Villa","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.msard.2025.106604_bib0019","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.msard.2025.106604_bib0056","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cen3.12107","article-title":"Evaluation of aquaporin-4 antibody assays","volume":"5","author":"Waters","year":"2014","journal-title":"Clin Exp Neuroimmunol"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:23:56Z","timestamp":1780039436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825003463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":57,"alternative-id":["S2211034825003463"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106604","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LATAM-Panorama-NMOSD: Epidemiological, Clinical, and Paraclinical Features of Neuromyelitis Optica Spectrum Disorder in Latin America and the Caribbean, A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106604"}}